Pa. Judge Urged To Make J&J CEO Testify In Risperdal Trial

By Matt Fair (January 18, 2019, 6:49 PM EST) -- A Pennsylvania state judge is weighing whether the CEO of Johnson & Johnson should be forced to take the stand at an upcoming trial over claims that labeling for the antipsychotic medication Risperdal failed to adequately warn about the risk of abnormal breast growth in adolescent boys....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Read the full article

Already a subscriber? Click here to login